Beam Therapeutics
BEAM
BEAM
208 hedge funds and large institutions have $3.43B invested in Beam Therapeutics in 2021 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 66 increasing their positions, 42 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
32% more funds holding
Funds holding: 157 → 208 (+51)
14% more capital invested
Capital invested by funds: $3.01B → $3.43B (+$422M)
5.22% more ownership
Funds ownership: 63.69% → 68.91% (+5.2%)
Holders
208
Holding in Top 10
10
Calls
$79.5M
Puts
$53.2M
Top Buyers
| 1 | +$292M | |
| 2 | +$189M | |
| 3 | +$47.4M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$41.3M |
| 5 |
PA
Perceptive Advisors
New York
|
+$37.8M |
Top Sellers
| 1 | -$99.7M | |
| 2 | -$71.5M | |
| 3 | -$66.4M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$60.2M |
| 5 |
Alkeon Capital Management
New York
|
-$40.8M |